{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T03:41:52Z","timestamp":1785642112818,"version":"3.56.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"14-16","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.lfs.2012.10.006","type":"journal-article","created":{"date-parts":[[2012,10,30]],"date-time":"2012-10-30T17:46:07Z","timestamp":1351619167000},"page":"815-820","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Probable involvement of Ca2+-activated Cl\u2212 channels (CaCCs) in the activation of CB1 cannabinoid receptors"],"prefix":"10.1016","volume":"92","author":[{"given":"Thiago Roberto Lima","family":"Romero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela da Fonseca","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor Dimitri Gama","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2012.10.006_bb0005","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nn1916","article-title":"Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors","volume":"10","author":"Agarwal","year":"2007","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.lfs.2012.10.006_bb0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1471-4159.1990.tb08815.x","article-title":"Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain","volume":"55","author":"Bidaut-Russell","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/j.lfs.2012.10.006_bb0015","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/28393","article-title":"Control of pain initiation by endogenous cannabinoids","volume":"394","author":"Calignano","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2012.10.006_bb0020","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/0024-3205(91)90154-4","article-title":"Opioid receptor-coupled second messengers","volume":"48","author":"Childers","year":"1991","journal-title":"Life Sci"},{"key":"10.1016\/j.lfs.2012.10.006_bb0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1172\/JCI200316116","article-title":"Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors","volume":"111","author":"Casanova","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lfs.2012.10.006_bb0030","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0166-2236(98)01283-1","article-title":"Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action","volume":"21","author":"Di Marzo","year":"1998","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.lfs.2012.10.006_bb0035","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1073\/pnas.92.8.3376","article-title":"Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide","volume":"92","author":"Facci","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.lfs.2012.10.006_bb0040","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev.pharmtox.38.1.179","article-title":"Cannabinoid receptors and their endogenous agonists","volume":"38","author":"Felder","year":"1998","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.lfs.2012.10.006_bb0045","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.0953-816X.2004.03177.x","article-title":"Effects of coadministration of cannabinoids and morphine on nociceptive behaviour, brain monoamines and HPA axis activity in a rat model of persistent pain","volume":"19","author":"Finn","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.lfs.2012.10.006_bb0050","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1152\/physrev.00004.2003","article-title":"Role of endogenous cannabinoids in synaptic signaling","volume":"83","author":"Freud","year":"2003","journal-title":"Physiol Rev"},{"key":"10.1016\/j.lfs.2012.10.006_bb0055","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0301-0082(99)00027-1","article-title":"Neuronal Ca2+-activated Cl\u2212 channels\u2014homing in on an elusive channel species","volume":"60","author":"Frings","year":"2000","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.lfs.2012.10.006_bb0060","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","article-title":"Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations","volume":"232","author":"Gali\u00e8gue","year":"1995","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.lfs.2012.10.006_bb0065","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0024-3205(97)00690-5","article-title":"Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors","volume":"61","author":"Gatley","year":"1997","journal-title":"Life Sci"},{"key":"10.1016\/j.lfs.2012.10.006_bb0070","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0163-7258(02)00250-4","article-title":"From cannabis to cannabinergics: new therapeutic opportunities","volume":"95","author":"Goutopoulos","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.lfs.2012.10.006_bb0075","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainres.2005.11.035","article-title":"Cannabinoid CB2 receptors: immunohistochemical localization in rat brain","volume":"1071","author":"Gong","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.lfs.2012.10.006_bb0080","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0022-3565(24)29472-6","article-title":"Fenamates: a novel class of reversible gap junction blockers","volume":"298","author":"Harks","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.lfs.2012.10.006_bb0085","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1146\/annurev.physiol.67.032003.154341","article-title":"Calcium-activated chloride channels","volume":"67","author":"Hartzell","year":"2005","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.lfs.2012.10.006_bb0090","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/S0024-3205(03)00651-9","article-title":"Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat","volume":"73","author":"Helyes","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.lfs.2012.10.006_bb0095","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1476-5381.1994.tb13177.x","article-title":"Action of niflumic acid on evoked and spontaneous calcium-activated chloride and potassium currents in smooth muscle cells from rabbit portal vein","volume":"112","author":"Hogg","year":"1994","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.lfs.2012.10.006_bb0100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0009-3084(02)00154-8","article-title":"Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives","volume":"121","author":"Hohmann","year":"2002","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.lfs.2012.10.006_bb0105","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1208\/aapsj080479","article-title":"Endocannabinoid mechanisms of pain modulation","volume":"8","author":"Hohmann","year":"2006","journal-title":"AAPS J"},{"key":"10.1016\/j.lfs.2012.10.006_bb0110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International Union of Pharmacology XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.lfs.2012.10.006_bb0115","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1152\/physrev.00029.2001","article-title":"Molecular structure and physiological function of chloride channels","volume":"82","author":"Jentsch","year":"2002","journal-title":"Physiol Rev"},{"key":"10.1016\/j.lfs.2012.10.006_bb0120","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1046\/j.1460-9568.2003.02957.x","article-title":"Activation of peripheral cannabinoid CB1 receptors inhibits mechanically evoked responses of spinal neurons in noninflamed rats and rats with hindpaw inflammation","volume":"18","author":"Kelly","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.lfs.2012.10.006_bb0125","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1476-5381.1996.tb15171.x","article-title":"Investigation of the effects of 5-nitro-2-(phenylpropylamino)-benzoic acid (NPPB) on membrane currents in rat portal vein","volume":"117","author":"Kirkup","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.lfs.2012.10.006_bb0130","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2174\/0929867306666220401153732","article-title":"The palmitoylethanolamide and oleamide enigmas: are these two fatty acid amides cannabimimetic?","volume":"6","author":"Lambert","year":"1999","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.lfs.2012.10.006_bb0135","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1021\/jm980363y","article-title":"Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists","volume":"42","author":"Lan","year":"1999","journal-title":"J Med Chem"},{"key":"10.1016\/j.lfs.2012.10.006_bb0140","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1124\/jpet.106.111385","article-title":"Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha","volume":"319","author":"LoVerme","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.lfs.2012.10.006_bb0145","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0165-6147(99)01339-5","article-title":"Pharmacological and biochemical interactions between opioids and cannabionoids","volume":"20","author":"Manzaneres","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.lfs.2012.10.006_bb0150","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1469-7793.2000.00249.x","article-title":"Distinct mechanisms for activation of Cl\u2212 and K+ currents by Ca2+ from different sources in mouse sympathetic neurones","volume":"527","author":"Mart\u00ednez-Pinna","year":"2000","journal-title":"J Physiol"},{"key":"10.1016\/j.lfs.2012.10.006_bb0155","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0165-5728(01)00323-X","article-title":"Comparative characterization in the rat of the interaction between cannabinoids and opiates for their immunosuppressive and analgesic effects","volume":"117","author":"Massi","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.lfs.2012.10.006_bb0160","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0306-4522(02)00870-9","article-title":"A peripheral cannabinoid mechanism suppresses spinal fos protein expression and pain behavior in a rat model of inflammation","volume":"117","author":"Nackley","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.lfs.2012.10.006_bb0165","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0306-4522(00)00202-5","article-title":"Role of the phosphatidylinositol-specific phospholipase C pathway in \u03b4-opioid receptor-mediated antinociception in the mouse spinal cord","volume":"99","author":"Narita","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.lfs.2012.10.006_bb0170","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejphar.2004.07.026","article-title":"Potassium channels and pain: present realities and future opportunities","volume":"500","author":"Oca\u00f1a","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.lfs.2012.10.006_bb0175","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1196\/annals.1369.052","article-title":"Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain","volume":"1074","author":"Onaivi","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.lfs.2012.10.006_bb0180","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2005.02.018","article-title":"\u03b4-Opioid receptor agonist SNC80 induces peripheral antinociception via activation of ATP-sensitive K+ channels","volume":"512","author":"Pacheco","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.lfs.2012.10.006_bb0185","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/bjp.2008.175","article-title":"The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors","volume":"154","author":"Pacheco","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.lfs.2012.10.006_bb0190","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1476-5381.2009.00310.x","article-title":"The \u03bc-opioid receptor agonist morphine, but not agonists at \u03b4 or \u043a-opioid receptors, induces central antinociception mediated by cannabinoid receptors","volume":"158","author":"Pacheco","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.lfs.2012.10.006_bb0195","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/j.2042-7158.2012.01472.x","article-title":"\u03b4-Opioid receptor agonist SNC80 induces central antinociception mediated by Ca2+-activated Cl\u2013 channels","volume":"64","author":"Pacheco","year":"2012","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.lfs.2012.10.006_bb0200","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejphar.2011.11.023","article-title":"Peripheral antinociception induced by \u03b4-opioid receptors activation, but not \u03bc- or \u03ba-, is mediated by Ca2+-activated Cl\u2013 channels","volume":"674","author":"Pacheco","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.lfs.2012.10.006_bb0205","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.lfs.2012.10.006_bb0210","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1046\/j.1440-1681.2000.03358.x","article-title":"Molecular characteristics and functional diversity of CLCA family members","volume":"27","author":"Pauli","year":"2000","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.lfs.2012.10.006_bb0215","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0163-7258(97)82001-3","article-title":"Pharmacology of cannabinoid CB1 and CB2 receptors","volume":"74","author":"Pertwee","year":"1997","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.lfs.2012.10.006_bb0220","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0301-0082(00)00031-9","article-title":"Cannabinoid receptors and pain","volume":"63","author":"Pertwee","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.lfs.2012.10.006_bb0225","first-page":"233","article-title":"A method for measurement of analgesic activity on inflamed tissues","volume":"113","author":"Randall","year":"1957","journal-title":"Arch Int Pharmacol"},{"key":"10.1016\/j.lfs.2012.10.006_bb0230","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0026-895X(25)08590-6","article-title":"Blockade of capacitive Ca2+ influx by Cl\u2212 channel blockers inhibits secretion from rat mucosal-type mast cells","volume":"47","author":"Reinsprecht","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.lfs.2012.10.006_bb0235","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.lfs.2011.01.017","article-title":"Endogenous cannabinoid receptor agonist anandamide induces peripheral antinociception by activation of ATP-sensitive K+ channels","volume":"88","author":"Reis","year":"2011","journal-title":"Life Sci"},{"key":"10.1016\/j.lfs.2012.10.006_bb0240","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1054\/plef.2001.0362","article-title":"Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy","volume":"66","author":"Rice","year":"2002","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.lfs.2012.10.006_bb0245","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/sj.bjp.0702351","article-title":"Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630","volume":"126","author":"Ross","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.lfs.2012.10.006_bb0250","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0022-3565(25)20744-3","article-title":"Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands","volume":"278","author":"Showalter","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.lfs.2012.10.006_bb0255","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1124\/jpet.104.080739","article-title":"Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice","volume":"314","author":"Varvel","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.lfs.2012.10.006_bb0260","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1161\/01.RES.81.5.711","article-title":"Unexpected and differential effects of Cl\u2212 channel blockers on the Kv4.3 and Kv4.2 K+ channels. Implications for the study of the I(to2) current","volume":"81","author":"Wang","year":"1997","journal-title":"Circ Res"},{"key":"10.1016\/j.lfs.2012.10.006_bb0265","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0006-8993(99)01908-3","article-title":"Synergistic interactions of endogenous opioids and cannabinoids systems","volume":"848","author":"Welch","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.lfs.2012.10.006_bb0270","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0026-895X(25)10907-3","article-title":"Niflumic and flufenamic acids are potent reversible blockers of Ca+2-activated Cl\u2212 channels in xenopus oocytes","volume":"37","author":"White","year":"1990","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.lfs.2012.10.006_bb0275","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s004240050478","article-title":"Volume-sensitive chloride current activated by hyposmotic swelling in antral gastric myocytes of the guinea-pig","volume":"435","author":"Xu","year":"1997","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.lfs.2012.10.006_bb0280","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0304-3940(00)01600-1","article-title":"Implications of Ca(2+)-activated Cl(\u2212) channels in the delta-opioid receptor-mediated antinociception in the mouse spinal cord","volume":"295","author":"Yamazaki","year":"2000","journal-title":"Neurosci Lett"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320512006091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320512006091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:11:09Z","timestamp":1758399069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320512006091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":56,"journal-issue":{"issue":"14-16","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0024320512006091"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2012.10.006","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Probable involvement of Ca2+-activated Cl\u2212 channels (CaCCs) in the activation of CB1 cannabinoid receptors","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2012.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}